Sept 2 (Reuters) - Yifan Pharmaceutical 002019.SZ :
* SAYS IT PLANS TO BUY DONGREN SINGAPORE, PERFECT TREND
VENTURES
FOR A COMBINED 716.3 MILLION YUAN ($100.99 million) IN ORDER TO
OWN STAKE IN BIOTON S.A. BIOP.WA
* SAYS IT WILL BECOME BIOTON'S BIGGEST SHAREHOLDER WITH
31.65%
HOLDINGS AFTER THE TRANSACTIONS
Source text in Chinese: http://bit.ly/2kodlXa
Further company coverage: 002019.SZ BIOP.WA
($1 = 7.0928 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((hongkong.newsroom@thomsonreuters.com; (8610)6627-1277;
Reuters Messaging: roxanne.liu@thomsonreuters.com))